FULC stock

Fulcrum Therapeutics Inc (FULC) financials · $427.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Fulcrum Therapeutics Inc (FULC) $427.0M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/A$80.0M
Operating Income-$84.8M-$21.9M
Net Income-$74.9M-$9.72M
EPS (Diluted)-$1.18-$0.16
Cached annual balance sheet
LineFY2025FY2024
Total Assets$366.3M$260.7M
Current Assets$357.5M$249.9M
Cash & Equivalents$197.5M$58.2M
PP&E$2.82M$3.90M
Total Liabilities$17.3M$17.7M
Current Liabilities$13.0M$11.0M
Shareholders' Equity$349.0M$243.0M
Retained Earnings-$594.3M-$519.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$60.1M-$2.22M
CapEx$314.0K$278.0K
Investing Cash Flow$30.7M$32.2M
Financing Cash Flow$168.7M$2.75M
Net Change in Cash$139.3M$32.8M
Free Cash Flow-$60.4M-$2.50M
These statements as JSON? API free 100/day

FAQ

What is FULC P/E and revenue?

Fulcrum Therapeutics Inc (FULC) $427.0M cap.

What is FULC revenue?

FULC income-statement cache has no revenue figure yet.

Is FULC profitable?

Fulcrum Therapeutics Inc last cached net income is -$74.9M (FY2025).

What are FULC total assets?

Fulcrum Therapeutics Inc last cached total assets are $366.3M (FY2025).

What is FULC free cash flow?

Fulcrum Therapeutics Inc last cached free cash flow is -$60.4M (FY2025).

Not investment advice. Cached statements, not a live tape.